Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Motor Activity 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Cancer Liver Metastases 1 Neoplasms 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Colorectal Neoplasms 1 Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1

Interventions

pembrolizumab 6 Cisplatin 5 Radiotherapy 4 Paclitaxel 3 Nivolumab 3 lenvatinib 2 Specimen Handling 2 Platinum 2 Papillomavirus Vaccines 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Gemcitabine 2 Carboplatin 2 CTLA-4 Antigen 2 Bleomycin 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 zimberelimab 1 rocakinogene sifuplasmid 1 liposomal doxorubicin 1 durvalumab 1 dostarlimab 1 cemiplimab 1 belzutifan 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alovudine 1 aldesleukin 1 Watchful Waiting 1 Vorinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Vulvar Neoplasms × Methods × Clear all

NCT01986725 2016-01-07

WOMAN-PROII

St.Gallen University of Applied Sciences

Phase 2 Completed

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡